Three mechanisms by which striatal denervation causes breakdown of dopamine Signaling

Journal of Neuroscience

Volumn 34, Issue 37, 2014, Pages 12444-12456

  Dreyer, Jakob K ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Compensation; D2 receptor; Dopamine; Parkinson s disease; Supersensitivity

Indexed keywords

ADULT; ALLOCENTRIC REPRESENTATION; ARTICLE; EGOCENTRIC REPRESENTATION; EYE MOVEMENT; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; HUMAN EXPERIMENT; MALE; PREDICTION; SIMULATION; SPATIAL MEMORY; TASK PERFORMANCE; VISUAL CORTEX; VISUAL STIMULATION; BIOLOGICAL MODEL; COMPUTER SIMULATION; CORPUS STRIATUM; DENERVATION; DOPAMINERGIC NERVE CELL; METABOLISM; NERVE CELL INHIBITION; PARKINSON DISEASE; PATHOPHYSIOLOGY; SIGNAL TRANSDUCTION; SURGERY;

DOPAMINE; DOPAMINE 2 RECEPTOR;

COMPUTER SIMULATION; CORPUS STRIATUM; DENERVATION; DOPAMINE; DOPAMINERGIC NEURONS; HUMANS; MODELS, NEUROLOGICAL; NEURAL INHIBITION; PARKINSON DISEASE; RECEPTORS, DOPAMINE D2; SIGNAL TRANSDUCTION;

EID: 84907015840     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.1458-14.2014     Document Type: Article

References (51)

1. Aghajanian GK, Wang RY, Baraban J (1978) Serotonergic and nonserotonergic neurons of the dorsal raphe: reciprocal changes in firing induced by peripheral nerve stimulation. Brain Res 153:169 -175. CrossRef Medline
2. Albin RL, Young AB, Penney JB (1989) The functional anatomy of basal ganglia disorders. Trends Neurosci 12:366 -375. CrossRef Medline
3. Barton AC, Sibley DR (1990) Agonist-induced desensitization of D1- dopamine receptors linked to adenylyl cyclase activity in cultured NS20Y neuroblastoma cells. Mol Pharmacol 38:531-541. Medline
4. Beaulieu JM, Gainetdinov RR (2011) The physiology, signaling, and pharmacology of dopamine receptors. Pharmacol Rev 63:182-217. CrossRef Medline
5. Bergstrom BP, Garris PA (2003) "Passive stabilization" of striatal extracellular dopamine across the lesion spectrum encompassing the presymptomatic phase of Parkinson's disease: a voltammetric study in the 6-OHDA-lesioned rat. J Neurochem 87:1224 -1236. CrossRef Medline
6. Bonci A, Hopf FW (2005) The dopamine D2 receptor: new surprises from an old friend. Neuron 47:335-338. CrossRef Medline
7. Brooks DJ, Ibanez V, Sawle GV, Playford ED, Quinn N, Mathias CJ, Lees AJ, Marsden CD, Bannister R, Frackowiak RS (1992) Striatal D2 receptor status in patients with Parkinson's disease, striatonigral degeneration, and progressive supranuclear palsy, measured with 11C-raclopride and positron emission tomography. Ann Neurol 31:184 -192. CrossRef Medline
8. Budygin EA, John CE, Mateo Y, Jones SR (2002) Lack of cocaine effect on dopamine clearance in the core and shell of the nucleus accumbens of dopamine transporter knock-out mice. J Neurosci 22:RC222(1-4). Medline
9. Cai G, Wang HY, Friedman E (2002) Increased dopamine receptor signaling and dopamine receptor-G protein coupling in denervated striatum. J Pharmacol Exp Ther 302:1105-1112. CrossRef Medline
10. Carta M, Carlsson T, Munoz A, Kirik D, Bjorklund A (2008) Involvement of the serotonin system in L-dopa-induced dyskinesias. Parkinsonism Relat Disord 14 [Suppl 2]:S154 -S158. CrossRef Medline
11. Caslake R, Macleod A, Ives N, Stowe R, Counsell C (2009) Monoamine oxidase B inhibitors versus other dopaminergic agents in early Parkinson's disease. Cochrane Database Syst Rev CD006661. CrossRef Medline
12. CastañedaE, Whishaw IQ, Robinson TE (1990) Changes in striatal dopamine neurotransmission assessed with microdialysis following recovery from a bilateral 6-OHDA lesion: variation as a function of lesion size. J Neurosci 10:1847-1854. Medline
13. Cragg SJ, Nicholson C, Kume-Kick J, Tao L, Rice ME (2001) Dopaminemediated volume transmission in midbrain is regulated by distinct extracellular geometry and uptake. J Neurophysiol 85:1761-1771. Medline
14. Dauer W, Przedborski S (2003) Parkinson's disease: mechanisms and models. Neuron 39:889 -909. CrossRef Medline
15. de la Fuente-Fernández R, Schulzer M, Mak E, Calne DB, Stoessl AJ (2004) Presynaptic mechanisms of motor fluctuations in Parkinson's disease: a probabilistic model. Brain 127:888-899. CrossRef Medline
16. Doucet G, Descarries L, Garcia S (1986) Quantification of the dopamine innervation in adult rat neostriatum. Neuroscience 19:427- 445. CrossRef Medline
17. Dreyer JK, Hounsgaard J (2013) Mathematical model of dopamine autoreceptors and uptake inhibitors and their influence on tonic and phasic dopamine signaling. J Neurophysiol 109:171-182. CrossRef Medline
18. Dreyer JK, Herrik KF, Berg RW, Hounsgaard JD (2010) Influence of phasic and tonic dopamine release on receptor activation. J Neurosci 30:14273- 14283. CrossRef Medline
19. Gerfen CR (2000) Molecular effects of dopamine on striatal-projection pathways. Trends Neurosci 23:S64 -70. CrossRef Medline
20. Gerfen CR (2003) D1 dopamine receptor supersensitivity in the dopaminedepleted striatum animal model of Parkinson's disease. Neuroscientist 9:455- 462. CrossRef Medline
21. Grace AA, Bunney BS (1984a) The control of firing pattern in nigral dopamine neurons: single spike firing. J Neurosci 4:2866 -2876. Medline
22. Grace AA, Bunney BS (1984b) The control of firing pattern in nigral dopamine neurons: burst firing. J Neurosci 4:2877-2890. Medline
23. Hobson DE, Pourcher E, Martin WR (1999) Ropinirole and pramipexole, the new agonists. Can J Neurol Sci 26 [Suppl 2]:S27-S33. Medline
24. Hornykiewicz O (2001) Chemical neuroanatomy of the basal ganglia– normal and in Parkinson's disease. J Chem Neuroanat 22:3-12. CrossRef Medline
25. Howard CD, Keefe KA, Garris PA, Daberkow DP (2011) Methamphetamine neurotoxicity decreases phasic, but not tonic, dopaminergic signaling in the rat striatum. J Neurochem 118:668-676. CrossRef Medline
26. Howard CD, Daberkow DP, Ramsson ES, Keefe KA, Garris PA (2013) Methamphetamine-induced neurotoxicity disrupts naturally occurring phasic dopamine signaling. Eur J Neurosci 38:2078 -2088. CrossRef Medline
27. Kish SJ, Shannak K, Hornykiewicz O (1988) Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinsons disease–pathophysiologic and clinical implications. N Engl J Med 318:876-880. CrossRef Medline
28. Knudsen GM, Karlsborg M, Thomsen G, Krabbe K, Regeur L, Nygaard T, Videbaek C, Werdelin L (2004) Imaging of dopamine transporters and D2 receptors in patients with Parkinson's disease and multiple system atrophy. Eur J Nucl Med Mol Imaging 31:1631-1638. CrossRef Medline
29. Kordower JH, Olanow CW, Dodiya HB, Chu Y, Beach TG, Adler CH, Halliday GM, Bartus RT (2013) Disease duration and the integrity of the nigrostriatal system in Parkinson's disease. Brain 136:2419 -2431. CrossRef Medline
30. Labandeira-Garcia JL, Rozas G, Lopez-MartinE, Liste I, Guerra MJ (1996) Time course of striatal changes induced by 6-hydroxydopamine lesion of the nigrostriatal pathway, as studied by combined evaluation of rotational behaviour and striatal Fos expression. Exp Brain Res 108:69-84. Medline
31. Lewis SJ, Caldwell MA, Barker RA (2003) Modern therapeutic approaches in Parkinson's disease. Expert Rev Mol Med 5:1-20. Medline
32. Lindgren HS, Dunnett SB (2012) Cognitive dysfunction and depression in Parkinson's disease: what can be learned from rodent models? Eur J Neurosci 35:1894 -1907. CrossRef Medline
33. Matsuda W, Furuta T, Nakamura KC, Hioki H, Fujiyama F, Arai R, Kaneko T (2009) Single nigrostriatal dopaminergic neurons form widely spread and highly dense axonal arborizations in the neostriatum. J Neurosci 29:444-453. CrossRef Medline
34. May T (1992) Striatal dopamine-D1-like receptors have higher affinity for dopamine in ethanol-treated rats. Eur J Pharmacol 215:313-316. CrossRef Medline
35. Obeso JA, Grandas F, Herrero MT, Horowski R (1994) The role of pulsatile versus continuous dopamine receptor stimulation for functional recovery in Parkinson's disease. Eur J Neurosci 6:889-897. CrossRef Medline
36. Paquette MA, Marsh ST, Hutchings JE, CastañedaE (2009) Amphetamineevoked rotation requires newly synthesized dopamine at 14 days but not 1 day after intranigral 6-OHDA and is consistently dissociated from sensorimotor behavior. Behav Brain Res 200:197-207. CrossRef Medline
37. Porter-Stransky KA, Seiler JL, Day JJ, Aragona BJ (2013) Development of behavioral preferences for the optimal choice following unexpected reward omission is mediated by a reduction of D2-like receptor tone in the nucleus accumbens. Eur J Neurosci 38:2572-2588. CrossRef Medline
38. Pothos EN, Davila V, SulzerD (1998) Presynaptic recording of quanta from midbrain dopamine neurons and modulation of the quantal size. J Neurosci 18:4106-4118. Medline
39. Prieto GA, Perez-Burgos A, Fiordelisio T, Salgado H, Galarraga E, Drucker- Colin R, Bargas J (2009) Dopamine D(2)-class receptor supersensitivity as reflected in Ca2+ current modulation in neostriatal neurons. Neuroscience 164:345-350. CrossRef Medline
40. Rangel-Barajas C, Silva I, Lopéz-SantiagoLM, Aceves J, Erlij D, FloránB (2011) L-DOPA-induced dyskinesia in hemiparkinsonian rats is associated with up-regulation of adenylyl cyclase type V/VI and increased GABA release in the substantia nigra reticulata. Neurobiol Dis 41:51- 61. CrossRef Medline
41. Reed MC, Best JA, Nijhout HF (2009) Passive and active stabilization of dopamine in the striatum. Biosci Hypotheses 2:240 -244. CrossRef
42. Robinson TE, Noordhoorn M, Chan EM, Mocsary Z, Camp DM, Whishaw IQ (1994) Relationship between asymmetries in striatal dopamine release and the direction of amphetamine-induced rotation during the first week following a unilateral 6-OHDA lesion of the substantia nigra. Synapse 17:16 -25. CrossRef Medline
43. Sandberg SG, Phillips PEM (2009) Phasic dopaminergic signaling: implications for Parkinson's disease. In: Cortico-subcortical dynamics in Parkinson's disease (Tseng K-Y, ed), pp 37-54. New York: Humana.
44. Schultz W (1998) Predictive reward signal of dopamine neurons. J Neurophysiol 80:1-27. Medline
45. Soghomonian JJ, Doucet G, Descarries L (1987) Serotonin innervation in adult rat neostriatum. I. Quantified regional distribution. Brain Res 425: 85-100. CrossRef Medline
46. StrömbergI, Kehr J, Andbjer B, Fuxe K (2000) Fetal ventral mesencephalic grafts functionally reduce the dopamine D2 receptor supersensitivity in partially dopamine reinnervated host striatum. Exp Neurol 164:154 -165. CrossRef Medline
47. Sun W, Sugiyama K, Fang X, Yamaguchi H, Akamine S, Magata Y, Namba H (2010) Different striatal D2-like receptor function in an early stage after unilateral striatal lesion and medial forebrain bundle lesion in rats. Brain Res 1317:227-235. CrossRef Medline
48. Syková E, NicholsonC (2008) Diffusion in brain extracellular space. Physiol Rev 88:1277-1340. CrossRef Medline
49. Toru M, Matsuda O, Makiguchi K, Sugano K (1981) Neuroleptic malignant syndrome-like state following a withdrawal of anti-Parkinsonian drugs. J Nerv Ment Dis 169:324 -327. CrossRef Medline
50. Ungerstedt U, Arbuthnott GW (1970) Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system. Brain Res 24:485- 493. CrossRef Medline
51. Weiner WJ, Koller WC, Perlik S, Nausieda PA, Klawans HL (1980) Drug holiday and management of Parkinson disease. Neurology 30:1257-1261. CrossRef Medline